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SwitzerlandABSTRACT Recent studies have revealed new insights into the endocytosis of vaccinia virus (VACV). However, the mecha-
nism of fusion between viral and cellular membranes remains unknown.We developed a microfluidic device with a cell-trap array
for immobilization of individual cells, with which we analyzed the acid-dependent fusion of single virions. VACV particles incor-
porating enhanced green fluorescent protein (EGFP) and labeled with self-quenching concentrations of R18 membrane dye
were used in combination with total internal reflection fluorescence microscopy to measure the kinetics of R18 dequenching
and thus single hemifusion events initiated by a fast low-pH trigger. These studies revealed unexpectedly long lag phases
between pH change and hemifusion. In addition, we found that EGFP fluorescence in the virus was quenched upon acidification,
indicating that protons could access the virus core, possibly through a proton channel. In a fraction of virus particles, EGFP
fluorescence was recovered, presumably after fusion-pore formation and exposure of the core to the physiological pH of the
host-cell cytosol. Given that virus-encoded cation channels play a crucial role in the life cycle of many viruses and can serve
as antiviral drug targets, further investigations into a potential VACV viroporin are justified. Our findings indicate that the micro-
fluidic device described may be highly beneficial to similar studies requiring fast kinetic measurements.INTRODUCTIONThe ultimate goal of a virus particle is to deliver the viral
genome into new host cells, thus allowing for production
of progeny viruses. One of the most challenging barriers
in this process is the plasma membrane, which surrounds
the host-cell cytosol. In the case of enveloped virus parti-
cles, this barrier is crossed by fusion of the virus membrane
with a cellular membrane. This process can take place at
the plasma membrane itself or at the limiting membrane
of an intracellular compartment after endocytosis of virus
particles. Triggers that induce the necessary protein rear-
rangements may involve receptor interactions and changes
in the physicochemical properties of the endosome, e.g.,
the pH (1).
Fusion mediated by simple viral fusion proteins, such as
the influenza A virus (IAV) hemagglutinin, the dengue virus
E protein, and the vesicular stomatitis virus (VSV) G pro-
tein, is well-understood, in part even in atomic detail (2).
The more complex fusion machinery of herpes- and poxvi-
ruses, in contrast, is less well understood and requires
further investigation (3–5).
Elucidating virus fusion is critical for a complete under-
standing of virus entry and may serve in the development
of antiviral agents that interfere with this process, such as
the HIV fusion inhibitor enfuvirtide (6). Moreover, virus
fusion serves as a model for the multitude of membraneSubmitted December 4, 2012, and accepted for publication June 6, 2013.
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0006-3495/13/07/0420/12 $2.00fusion events that take place throughout the cell, in both
the secretory pathway and the endocytic system (7,8).
Bulk fusion kinetics have traditionally been obtained by
using virus particles (or liposomes) labeled with self-
quenching quantities of the lipophilic dye octadecyl rhoda-
mine B chloride (R18) (9). For this, virus particles are bound
to cells in suspension and total R18 fluorescence in a cuvette
is measured in a fluorometer. Fusion is detected as the in-
crease of R18 fluorescence—a direct consequence of hemi-
fusion and thus dequenching of R18 due to its dilution into
cellular membranes. Measuring fusion in bulk, however,
cannot resolve single fusion events and may therefore
obscure heterogeneities in virus populations or fusion ki-
netics. Furthermore, fusion at the plasma membrane cannot
be directly distinguished from fusion with limiting mem-
branes of endocytic vesicles.
Supported lipid bilayers (SLBs) are compatible with
planar microfluidic devices and have therefore been used
to visualize and quantify single fusion events of viruses
and vesicles (10,11). However, this approach requires artifi-
cial membranes that are restricted in lipid composition such
that, for instance, only low concentrations of cholesterol are
possible (12). Thus, SLBs do not accurately reflect the situ-
ation of a complex biological membrane. SLB experiments
are, in addition, limited to conditions in which all necessary
factors for binding and fusion—mostly proteins and lipids—
are known and compatible with the generation of SLBs.
We aimed to pursue single-virus fusion experiments with
vaccinia virus (VACV), a complex DNA virus that serves as
the model poxvirus and is closely related to variola virus, the
causative agent of smallpox (13). We chose the more abun-
dant mature virions (MVs) for our studies, as their singlehttp://dx.doi.org/10.1016/j.bpj.2013.06.016
Single Vaccinia Virus Fusion Analysis 421membrane can fuse with different cellular membranes and is
amenable to labeling. MVs normally fuse with the limiting
membranes of intracellular endocytic organelles after
uptake by endocytosis (4,14,15). In the case of VACV strain
Western Reserve (WR), fusion is triggered by acidification
of endosomes (14). It is important to note that fusion at
the plasma membrane can also be artificially triggered by
briefly treating MVs bound to the plasma membrane with
a low-pH buffer at 37C (16). Although it is clear that the
11 subunits of the VACV entry fusion complex (EFC) are
required for fusion (5), the requirements for the acceptor
membrane are poorly understood. In fact, preliminary
experiments suggest that VACVMVs do not bind efficiently
to a variety of artificial membranes, indicating the need for
an experimental system with native biological membranes
(Fig. S1 in the Supporting Material).
Total internal reflection fluorescence (TIRF) microscopy
allows the visualization of plasma membrane events, such
as clathrin-mediated endocytosis of VSV (17), and could in
principle be used to visualize fusion at the plasmamembrane.
Since endocytosed virus particles leave the evanescent field
of the TIRF microscope, no extra measures, such as inhibi-
tion of endosomal acidification, need be undertaken to distin-
guish between fusion at the plasma membrane or from
endocytic vesicles. However, due to their size, VACV MVs
do not diffuse under adherent cells and therefore cannot be
analyzed using the conventional TIRF microscopy ap-
proaches used for other virus entry studies.
Microfluidic devices arewidely used for single-cell studies
due to the similar size of their channels and thus the possi-
bility to passively immobilize single cells (18,19). To date,
single-cell experiments based on microfluidic technology
have yielded important insights, which would be obscured
by measurements of the whole population (20–22).
To study single fusion events of VACV MVs, we estab-
lished a microfluidic device that trapped suspension cells
with bound R18-labeled virus particles in hurdle structures
(Fig. 1). As the buffer flow gently pressed the cells against
the underlying coverslip, virions bound to the plasma mem-
brane were brought into the evanescent field of a TIRF
microscope. Fluorescence of R18 in the virus membrane,
as well as a fluorescent protein in the virus core, could be
detected microscopically during low-pH-induced fusion.
The pH was monitored using fluorescein-isothiocyanate-
labeled bovine serum albumin (BSA-FITC) immobilized
to the coverslip by microcontact printing (23). This allowed
us to measure the kinetics of single hemifusion events and to
determine lag phases and R18 dequenching rates for indi-
vidual virus particles. Our studies further reveal that the
fluorescence of EGFP fused to a core protein was quenched
upon acidification of the extracellular milieu. The recovery
of EGFP fluorescence indicated that contact with the host-
cell cytosol after fusion-pore formation brought the EGFP
back to physiological pH. These findings suggest that the
VACV membrane contains a proton channel.MATERIALS AND METHODS
For details of the microfabrication, image acquisition, and data analysis, see
the Supporting Material.Reagents
2-(N-morpholino)ethanesulfonic acid (MES), tris(hydroxymethyl)amino-
methane, Triton X-100, BSA, BSA-FITC, and hexamethyldisilazane
(HMDS) were obtained from Sigma Aldrich (St. Louis, MO). SU-8 3005,
SU-8 2050, AZ1518, and developers for the resists were bought from
Microchem (Newton, MA). Poly(dimethylsiloxane) (PDMS) (Sylgard
184) was from Dow Corning (Midland, MI). 1H,1H,2H,2H-Perfluoro-
decyl-dimethylchlorosilane was obtained from ABCR (Karlsruhe,
Germany). R18 and phosphate-buffered saline (PBS) were from Invitrogen
(Carlsbad, CA). Hybridoma cells to produce themouse anti-L1 (monoclonal
antibody (MAb) 7D11) (24) were kindly provided by Bernard Moss
(National Institutes of Health, Bethesda, MD) with permission of Alan
Schmaljohn (University of Maryland, Baltimore, MD). MAbs were purified
from hybridoma supernatants by BioGenes (Berlin, Germany).Cell lines
BSC-40 (African green monkey) were cultivated in DMEM (Life Technol-
ogies, Carlsbad, CA) supplemented with 10% heat-inactivated fetal calf
serum, GlutaMAX, nonessential amino acids, sodium pyruvate, and peni-
cillin-streptomycin. HeLa S3 suspension cells were grown in RPMI 1640
GlutaMAX medium (Life Technologies) with 10% heat-inactivated fetal
calf serum, nonessential amino acids, and penicillin-streptomycin in a
spinner bottle.Viruses
R18-labeled MVs of VACV strains WR EGFP-A4 (25) or WR EL EGFP
(15) were produced in BSC-40 cells and purified/labeled as described pre-
viously (26). MVs from cytosolic extracts were sedimented through a 36%
sucrose cushion (80 min, 43,000  g, 4C), resuspended in 10 mM TRIS,
pH 9.0, and incubated with R18 at a final concentration of 22.5 mM for 2 h
at room temperature. Labeled MVs were sedimented (40 min, 38,000  g,
4C) and purified through a 25–40% sucrose gradient (50 min, 12,000  g,
4C). Virus from aspirated bands was sedimented one last time (40 min,
38,000  g, 4C). MVs were resuspended in 1 mM TRIS, pH 9.0, and
stored at 80C. Self-quenching of R18 in the v membrane was verified
by comparing emission spectra of virus suspensions in PBS and 1% Triton
X-100/PBS using a Cary Eclipse fluorescence spectrophotometer (Varian,
Palo Alto, CA) with excitation wavelength of 560 5 5 nm and emission
wavelengths from 565 to 750 nm5 5 nm. As negative controls for fusion,
labeled MVs were neutralized by incubation with 100 mg/mL 7D11, a
mouse monoclonal anti-L1 antibody, for 1 h at 37C.Bulk fusion experiments
To monitor fusion in bulk, R18-dequenching during low-pH-induced fusion
was measured using a Cary Eclipse fluorescence spectrophotometer
(Varian) with an excitation wavelength of 560 5 5 nm and an emission
wavelength of 590 5 5 nm. To measure R18 and EGFP fluorescence in
the same experiments (using the same photomultiplier tube settings),
EGFP fluorescence was excited with 488 5 5 nm and measured at
509 5 10 nm, whereas R18 was excited with 560 5 5 nm and measured
at 640 5 5 nm. R18 fluorescence was measured at wavelengths longer
than the emission maximum to adjust the signal intensities to the EGFP
fluorescence. R18-labeled WR EGFP-A4 MVs were bound to 7  105
HeLa S3 cells in the cold (MOI 30). After 1 h, cells were sedimentedBiophysical Journal 105(2) 420–431
FIGURE 1 Illustration of the microfluidic
device used for cell-virus fusion. (a) Fluids are
withdrawn through the channel network from a
reservoir with a syringe pump. Posts inside the
channel act as filters to retain large agglomerates
of cells and debris, whereas single cells are
captured in cell traps (see brightfield image). (b)
The working principle of cell traps. Without a trap-
ped cell, the fluid can pass under the traps. After a
cell has been trapped, the flow is diverted (around
the cell), making it unlikely to trap more than one
cell. Microcontact-printed BSA-FITC is used to
monitor the pH inside the channel directly next
to the cell. (c) Side view of the set-up. The cell is
slightly pressed onto the glass by the buffer flow.
Single virus particles are imaged by two-color
TIRF microscopy with an evanescent field of
250 nm.
422 Schmidt et al.and resuspended in 100 mL PBS. The cell suspension with bound virions
was added to 900 ml prewarmed PBS in a 1.5 ml fluorescence cell
(119.004-QS, Hellma, Mu¨llheim, Germany). After 1 min, the pH in the
cuvette was lowered by addition of 100 ml MES solution (0.063–1 M), re-
sulting in a pH of 6.5 to 5.0. R18 fluorescence was measured for 10 min,
when all R18 was dequenched by the addition of 110 ml 10% Triton X-
100. R18 fluorescence was normalized to the signal intensity after Triton
X-100 addition.Single-virus-particle fusion experiment
R18-labeled VACV MVs or IAV particles were bound to 5  105 HeLa S3
suspension cells (MOI 5) at 4C. After 1 h, cells were sedimented and
resuspended in 500 ml PBS. The microfluidic device and all solutions
were warmed to 37C in the incubation chamber of the TIRF microscope.
This avoided bubbles in the device and ensured that the temperature was
correct for the fusion experiment. Fluids were withdrawn through the chan-
nels with a neMESYS pump (cetoni, Korbussen, Germany) operating a
2.5 ml Hamilton glass syringe that was connected with Teflon tubing to
the chip. Cell suspension (50 ml) was loaded into the chip at a flow rate
of 5 ml/min. Cells that were not trapped in the hurdles were washed away
with PBS at the same flow rate.Biophysical Journal 105(2) 420–431A field of view containing several cells with single virus particles was
identified by TIRF microscopy and fusion of bound MVs with the plasma
membrane was induced by changing the buffer from PBS (pH 7.4)
to 90 mM MES in PBS (pH 5.0). While changing the solution in the
reservoir, the flow rate was reduced to the minimal flow sufficient to
keep the cells in place (0.1 ml/min). This ensured that the pH drop in
the field of view occurred rapidly and with some delay after buffer ex-
change. Immediately after the beginning of acquisition, the flow rate
was increased to 5 ml/min again. The decrease in pH at the cell traps
occurred ~15 s later.pH-Dependent fluorescence of virus particles
A chip that has not been blocked with BSA was filled with 50 ml vaccinia
virus MVs in 1 mM TRIS, pH 9.0 (108 pfu/ml). MVs were allowed to bind
to the glass for 1 h at room temperature. Binding was performed at pH 9.0 to
prevent aggregation of virus particles. All nonbound particles were washed
out with 1 mM TRIS, pH 9, which was then replaced with PBS at pH 7.4. A
flow of 20 ml/min or no flow (when the buffer in the reservoir was
exchanged) was used in these experiments. Fluorescence of EGFP-A4 in
the virus core was subsequently measured during the change of buffer
from PBS to 90 mM MES in PBS (pH 5.0), and vice versa.
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Bulk fusion experiments
To measure bulk and single-particle fusion of VACV MVs
with cellular membranes, we labeled MV membranes with
self-quenching quantities of R18. We used VACV strain
WR EGFP-A4, which encodes the bona fide core protein
A4 (also known as p39, A4L, A5, or A5L) as an EGFP
fusion protein (23,24). EGFP-A4 is incorporated into virus
cores and allows the visualization of both MVs and released
cores after fusion (25). We obtained virus stocks with titers
in the order of magnitude of unlabeled MVs, indicating that
infectivity was not impaired. To test whether R18 in virus
membranes was self-quenched, we measured the fluores-
cence spectra of virions in the absence and presence of
1% Triton X-100 (Fig. 2 a). At the emission maximum,
R18 fluorescence in the presence of detergent was ~20-
fold higher than in its absence, confirming that R18 in the
MV membrane was quenched.
To date, bulk fusion of R18-labeled VACV MVs has
mostly been measured in cells kept at physiological pH,
where fusion was presumed to occur after endocytic uptake
(25,26). Acid-induced fusion has been investigated indi-
rectly by quantifying polykaryon formation, i.e., cell-cell
fusion (16,27). During polykaryon formation, acid-induced
fusion of virus particles with the plasma membrane is
thought to deposit viral fusion proteins in the plasma
membrane, which can subsequently mediate fusion of the
infected cell with neighboring cells. In some cases, R18
dequenching or infection at physiological pH was measured
after a short low-pH treatment of MVs bound to the plasma
membrane (14,26). To measure acid-induced bulk fusion
directly, and to determine the optimal pH for VACV MV
fusion, we first measured acid-induced bulk fusion ofFIGURE 2 Bulk fusion experiments. (a) Emission spectra of R18-labeled VAC
respectively) of 1% Triton X-100. (b) pH dependence of fusion. R18-labeled WR
PBS at t¼ 0 min. The pH was lowered to the indicated pH by addition of differen
over time. virus membranes were solubilized and R18 completely dequenched b
neutralized with antibody 7D11. Experimental setup is as in b, except that R18-la
presence of 100 mg/ml 7D11 before binding.R18-labeled MVs to HeLa S3 suspension cells in a fluores-
cence spectrophotometer (Fig. 2 b). Of the physiological pH
values tested, pH 5.0 resulted in the optimal, i.e., fastest and
most complete, fusion and was chosen for further fusion
experiments. More than 30% of all virions fused within
10 min after acidification. In the measured time, no or
only minor amounts of fusion were detected at pH 7.4.
To test whether R18 dequenching was indeed the conse-
quence of a genuine fusion event, we analyzed fusion of
MVs pretreated with the neutralizing anti-L1 antibody
7D11, which has been described as inhibiting virus fusion
(25). We found that R18 fluorescence of 7D11-pretreated
MVs did not increase over time when treated at pH 5.0
(Fig. 2 c). This indicated that R18 dequenching required
fusion and was not caused by the applied low-pH or nonfuso-
genic dye transfer.Detection of single-particle fusion
To visualize and record single-virus fusion events, we em-
ployed a microfluidic device in which single HeLa S3 cells
with bound R18-labeled MVs were trapped (Fig. 1). Fluo-
rescent virions could be followed on the microscope over
time and—more important—during fusion with the plasma
membrane induced by rapid exchange to a pH 5.0 buffer
(within one frame). HeLa S3 suspension cells with bound
VACV MVs were loaded into the microfluidic device. The
trapped cells were imaged by TIRF microscopy with an
evanescent field of ~250 nm. Hence, only virions directly
in contact with the cell membrane and in close proximity
to the glass were excited. In a typical experiment, we re-
corded three to four cells with approximately one to five
detectable virions (Fig. 3). Virions were only considered if
fluorescence could be clearly detected in both channelsV WR EGFP-A4 in PBS in the absence and presence (black and red lines,
EGFP-A4MVs were bound to HeLa S3 cells in the cold and added to warm
t concentrations of MES buffer at t¼ 1 min and R18 fluorescence followed
y the addition of Triton X-100 (1% final) at t ¼ 11 min. (c) Fusion of MVs
beled WR EGFPA4MVs were incubated for 1 h at 37C in the absence and
Biophysical Journal 105(2) 420–431
FIGURE 3 Images from a typical microfluidic
experiment. R18-labeled WR EGFP-A4 MVs
were bound to HeLa S3 cells in the cold. Cells
were subsequently trapped in a microfluidic cham-
ber and detected with TIRF microscopy at 37C.
At t ¼ 26 s, PBS was replaced with MES/PBS
(pH 5.0). The left column shows a complete field
of view (both channels merged). At time zero, sin-
gle virions could be easily identified due to the
colocalization of the R18 and EGFP signals; cells
are marked with dashed circles. The other columns
represent magnifications of the cell highlighted
with the bold circle. The middle column shows
the fluorescence of EGFP-A4, and the right column
shows the corresponding R18 signal. Arrows mark
two typical virus particles undergoing fusion.
When the pH was decreased, an immediate
decrease of the EGFP fluorescence in the cores,
as well as of the pH sensor signal, was observed.
After a few seconds (t ¼ 107 s), the signal at the
membrane increased significantly due to hemi-
fusion and dye dequenching. At the end of the
experiment (t ¼ 339 s), the fluorescence in the
core is partly recovered in some of the virions,
whereas R18 was distributed throughout the
plasma membrane.
424 Schmidt et al.(R18 and EGFP) before the pH decrease. Single virus parti-
cles and their fluorescence were tracked throughout the
experiment using the fluorescence of the virus core protein
EGFP-A4, since R18 was redistributed into the plasma
membrane during acid-induced fusion.
Acquisition was started immediately after changing the
buffer in the fluid reservoir of the microfluidic device from
pH 7.4 to pH 5.0, and it continued for ~5 min. The pH 5.0
buffer arrived in the field of view ~15 s after buffer exchange.
After the decrease in pH, the fluorescence intensity of the
BSA-FITC microspots and the core EGFP-A4 dropped
immediately. At the time resolution used (3–4 s), we could
not observe any lag time between the changes of fluorescence
intensity of the directly accessible BSA-FITC and the mem-
brane-surrounded EGFP-A4 within the virus core. This
observation will be discussed in more detail later. After aBiophysical Journal 105(2) 420–431lag phase, the loss of fluorescence intensity in the green chan-
nel was followed by a gradual increase in R18 fluorescence in
virus particles. The increase in R18 fluorescence was caused
by dilution of the dye into the plasma membrane. Although
an increase in R18 fluorescence does not strictly rule out
the simultaneous merger of both leaflets of the membrane
bilayers, it is generally accepted that virus fusion involves
a hemifusion intermediate, which is sufficient for R18
dequenching (28). The fact that the VACV MV membrane
protein L1 is required for acid-induced syncytia formation
(fusion from within) (29), but not for R18 dequenching in
the course of a normal infection (26), supports a two-step
model of VACV fusion. We therefore refer to R18 dequench-
ing in the case of VACVas a readout for hemifusion. No R18
dequenching was observed when the trapped cells with
bound virions were kept at pH 7.4 (Fig. S3).
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virus particles
To analyze single fusion events, we plotted the R18 fluores-
cence of individual tracked virions over time (Fig. 4 a). We
calculated the fluorescence increase for each single particle
and only considered those particles that at least doubled in
fluorescence (increase >100%; 33 of 177 tracked particles).
We next extracted the lag phases between the pH shift and
the onset of R18 dequenching, i.e., hemifusion (Fig. 4 b).
This uncovered an unexpected heterogeneity in the lag
phases that was not detected in the bulk fusion experiments,
in which no clear lag phases were observed. Although hemi-
fusion started in most virions between 8 and 24 s after the
pH drop, lag phases ranged from a few seconds up to 77 s
after pH shift.
When acid-induced fusion of R18-labeled IAV X31 with
HeLa S3 cells was visualized as a control in our microfluidic
setup (Fig. S4), clear lag phases before hemifusion were also
observed.
The rate of R18 dequenching during VACV fusion was
homogeneous (Fig. 4 c), but much slower than typically
observed after fusion of single virus particles with SLBs
(10,30). R18 fluorescence increased for ~1 min during
MV fusion before reaching a plateau, and IAV fusion
occurred with similar kinetics. The dequenching rate is
expected to depend mainly on the diffusion of R18 dye
into the cell membrane, and therefore, R18 dequenching
likely follows similar kinetics for all virus particles. Dissipa-
tion of R18 fluorescence was sporadically observed at later
times (>200 s), although R18 fluorescence from fusion
events outside the illuminated region obscured the fluores-
cence of single virions in most cases.
Neither hemifusion lag phases nor the rate of R18
dequenching correlated with the detected R18 fluorescence
intensity before fusion (Fig. S5). Lag-phase duration and
R18 dequenching rates also did not correlate (Fig. S5), sug-
gesting that the measured properties were not influenced byFIGURE 4 R18 dequenching of single virus particles. (a) Normalized R18 flu
setup described in Fig. 3. The dashed line is the fluorescence of microcontact-prin
set as t ¼ 0 s. (b and c) Lag-time distribution (b) and dequenching rate (c) of athe amount of R18 incorporated into virus membranes. Due
to the stringent conditions used to select fusion events to be
analyzed, the percentage of MVs undergoing fusion was not
quantified. The applied conditions were, however, identical
to those used in bulk fusion experiments.Acidification of EGFP-containing cores
In all of our experiments, we observed that the EGFP fluo-
rescence inside the core quickly decreased after the pH
in the microfluidic device was lowered (Fig. 5 a). This
decrease was followed by an increase of R18 fluorescence,
i.e., hemifusion. In some instances, EGFP fluorescence
recovered (see also Fig. 5, b and c).
The GFP variant used, EGFP, is pH-sensitive, with an
apparent pK0a of 6.15, and the loss in fluorescence intensity
at acidic pH is reversible down to a pH of 5.0 (31). The
reduced fluorescence intensity of EGFP-A4 after the pH
drop can thus be correlated to a reduced pH in the virus
core. Nevertheless, the observed EGFP quenching in the
core was surprising because the lipid bilayer surrounding
the virus core was expected to be highly impermeable to
protons.
As R18 fluorescence did not decrease upon the pH drop,
and the EGFP fluorescence dropped in every core observed,
we could exclude that loss of EGFP fluorescence was due to
movement of the virus particle out of the focal plane. We
therefore hypothesize that the VACV MV membrane con-
tains proton channels that transmit protons into the virus
interior along a concentration gradient.pH-Dependent EGFP fluorescence
of immobilized MVs
To further investigate core acidification, we designed an
additional experiment to measure the pH-dependent fluores-
cence of many virus particles simultaneously. We used theorescence traces of single vaccinia virions obtained with the experimental
ted BSA-FITC and thus corresponds to the pH. The time of the pH drop was
ll measured virus particles (n ¼ 33).
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FIGURE 5 EGFP recovery after fusion-pore opening. (a) Time series of two virions fusing with the plasma membrane, obtained with the experimental
setup described in Fig. 3. The EGFP-A4 signal (upper row) quickly decreased after the pH drop at time zero, but began to recover after ~100 s. The R18
signal (lower row) augmented during hemifusion, reached a maximum at 120 s, and decreased again later, presumably because the dye was diluted into
the plasma membrane. Virus particles moved laterally with the cells, suggesting that they were not bound to the surface of the chip. (b) Normalized fluo-
rescence traces (R18, open symbols; EGFP, solid symbols) of the virus particles in a. (c) Representative normalized fluorescence curves of EGFP-A4 fluo-
rescence after pH decrease. Fluorescence recovered in some virions, whereas it remained quenched in others. Dashed lines in both graphs represent the
fluorescence of the pH sensor BSA-FITC and indicate when the pH was lowered.
426 Schmidt et al.same microfluidic device, but did not block the surfaces
with BSA. WR EGFP-A4 MVs were then introduced into
the device and incubated at room temperature to allow bind-
ing to the glass bottom through electrostatic interactions.
Binding and acquisition of many virus particles in one focal
plane provided several advantages: no MVs could leave the
focal plane due to cell movement, and buffers could be
exchanged more rapidly and multiple times without the
risk of losing trapped cells. Since no R18 fluorescence
was recorded, EGFP fluorescence could be acquired at a
higher frame rate (2 s). Fig. S6 shows a typical experiment
performed with ~100 virus particles. As before, BSA-FITC
was used as a pH sensor in the microfluidic device. We
observed that the pH drop in the channel coincided with a
strong decrease in EGFP-A4 fluorescence in MVs. Since
this phenomenon was observed in all virus particles, it is
highly unlikely that virions are proton-permeable due to
defects in the membrane. When the pH in the same micro-
fluidic device was changed back to pH 7.4, EGFP fluores-
cence increased rapidly. This indicates that the low-pHBiophysical Journal 105(2) 420–431quenching of EGFP is reversible, and that protons can pre-
sumably cross the virus membrane in both directions.
Although virus-encoded proton channels are diverse and
no general proton-channel inhibitor exists (32), two unre-
lated viral ion channels, the IAV proton channel M2, and
the hepatitis C virus cation channel p7, are sensitive to
amantadine (33,34). When WR EGFP-A4 MVs were pre-
treated and kept in amantadine or the related compound
rimantadine, we observed that the EGFP-A4 fluorescence
was still quenched at low pH (Fig. S7), indicating that proton
influx into VACVMVs was insensitive to adamantane-based
inhibitors.Recovery of EGFP-A4 fluorescence in single
virions after fusion
When EGFP-A4 containing cores were followed over time
in single-virus fusion experiments, we repeatedly observed
that EGFP fluorescence recovered with some delay after
hemifusion. On average, EGFP recovery started after
Single Vaccinia Virus Fusion Analysis 427121 s and reached 36% of the fluorescence intensity before
the pH drop (n¼ 8). Since R18 fluorescence was recorded at
the same time and did not exhibit equivalent changes, we
can rule out that the increase in EGFP fluorescence occurred
due to the movement of virus particles into the focal plane.
As acid-quenching of EGFP was shown to be reversible, it is
likely that EGFP recovery occurred when the pH within the
virus core returned to a physiological level. This is expected
to happen when virus cores gain access to the host-cell
cytosol after fusion-pore formation. Due to their membrane
potential and the energy-dependent transfer of protons
against the concentration gradient, cells can presumably
sustain a physiological pH despite their acidic surrounding.
The cellular cytosol, with a volume that is multiple orders of
magnitude larger than that of the virus, may buffer the acidic
pH in the virus interior. Thus, recovery of EGFP fluores-
cence would indicate successful fusion-pore formation.
However, since recovery of EGFP-A4 fluorescence was
comparatively slow, we cannot rule out that neutralization
of the virus core is somewhat delayed. This may be due to
the ongoing activity of viral proton channels. Alternatively,
the hemifusion intermediate during VACV MV fusion may
be exceptionally stable.FIGURE 6 Bulk fusion experiments. R18-labeled WR EGFP-A4 MVs
were incubated for 1 h at 37C in the absence and presence of 100 mg/ml
7D11 and bound to HeLa S3 cells in the cold. The cell-virus suspension
was added to warm PBS at t ¼ 0 min and R18 (a) and EGFP (b) fluores-
cence was measured. The pH was lowered to pH 5.0 by addition of MES
buffer at t ¼ 1 min and fluorescence was recorded for 10 min.Recovery of EGFP-A4 fluorescence after fusion
in bulk
Based on our observations in single-particle experiments,
EGFP quenching and recovery should also be detectable
in bulk fusion experiments. Furthermore, EGFP recovery
would only be expected to occur when fusion takes place.
To test this, we used R18-labeled WR EGFP-A4 MVs for
bulk fusion experiments in a fluorescence spectrophotom-
eter in which both R18 and EGFP fluorescence of bound
virions could be detected (Fig. 6). As in single-virus fusion
experiments, bulk EGFP-A4 fluorescence intensity immedi-
ately dropped when the pH was lowered to 5.0; R18
dequenching, and thus hemifusion formation, directly fol-
lowed acidification. As seen in the single-virus experiments,
EGFP fluorescence recovered with time after hemifusion,
reaching ~20% of its intensity before low-pH treatment.
This is in line with our single-virus fusion experiments, in
which EGFP fluorescence was recovered in only a fraction
of the observed MVs. When MVs were pretreated with
the neutralizing antibody 7D11 before binding, EGFP-A4
fluorescence decreased upon low-pH treatment as in the
untreated controls; however, neither R18 dequenching nor
EGFP recovery could be observed in the sample. This con-
firms that 7D11 blocks hemifusion, and that EGFP recovery
only occurs after hemifusion formation. This suggests that
EGFP recovery is most likely a consequence of fusion-
pore formation.
Taken together, our data suggest a model in which EGFP
fluorescence in the core is quenched by pH 5 buffers
because the virus interior is acidified (Fig. 7). EGFP fluores-cence recovers over time, presumably after fusion-pore for-
mation and content mixing with the host-cell cytosol.DISCUSSION
We established an experimental setup to visualize single,
acid-induced VACV fusion events at the plasma membrane.
This permits the quantification of single-virus fusion ki-
netics and couples the measurement of hemifusion to micro-
scopic observation of virus or cell components, exemplified
in this study by a fluorescent virus core protein.
In contrast to similar setups described previously (10),
fusion was analyzed with biological membranes rather than
with nonphysiological lipid mixtures. This allows fusion
studies under physiological conditions and is particularly
helpful for analysis of virus fusion events for which the bind-
ing and fusion requirements are unknown. Furthermore, theBiophysical Journal 105(2) 420–431
FIGURE 7 Model of acid-induced fusion of VACV MV with the plasma
membrane. (a) VACV MVs are bound to the cell at physiological pH. (b)
When the buffer is exchanged to pH 5, protons enter the virus particle, pre-
sumably through proton channels, and quench EGFP fluorescence. (c) After
a lag time, hemifusion occurs, which is monitored by R18 dequenching. (d)
After complete fusion (fusion-pore opening), the interior of the virus is
buffered by the cell cytosol, leading to the recovery of EGFP fluorescence.
428 Schmidt et al.fusion analyzed was directly coupled to a genuine infection,
which we could verify using a virus strain expressing EGFP
under the control of a viral promoter (Fig. S8).
In this study, we used VACV MVs as an example of a
complex enveloped virus for which the fusion step is poorly
characterized. Previously, information on single-virus
fusion events was not available. Fusion in general hadBiophysical Journal 105(2) 420–431only been studied in bulk experiments under conditions in
which fusion occured asynchronously without distinguish-
ing between fusion in endocytic vesicles and fusion at the
plasma membrane (25,26). Although it is possible that
different triggers induce MV fusion, it is widely accepted
that cell-bound MVs of strain WR can be artificially fused
with the plasma membrane by low-pH treatment. Using ar-
tificially triggered fusion, it is ensured that all detected virus
particles receive the signal for fusion at the same time.
Observed heterogeneities in fusion under control or per-
turbed conditions can therefore directly be attributed to
the fusion process itself. Using both bulk and single fusion
experiments, we confirmed acid-induced fusion of WR
MVs. Single fusion experiments allowed us to extend the in-
formation on MV fusion by revealing variable lag time be-
tween acidification and hemifusion, R18 dequenching rates,
and the timing of fusion-pore formation.
Lag phases between acidification and R18 dequenching
have been repeatedly observed in bulk acid-mediated fusion
experiments using different viruses, such as IAV, VSV, or
Semliki Forest virus (35–37). In many cases, however, lag
phases at optimal fusion conditions were short and could
only be accurately observed using specifically designed
stopped-flow experiments or by slowing hemifusion using
nonphysiological temperatures or suboptimal pH. The lag
phase was interpreted as the time needed for changes in
the quaternary structure and conformation of the fusion
proteins to allow for fusion (38).
Our single VACV and IAV fusion experiments revealed
that substantial lag times occurred under optimal fusion con-
ditions. Similar lag times had been measured when octa-
decyl-rhodamine-110-labeled IAV particles were bound to
SLBs and acid-induced fusion events of single virions
were observed at 23C (10). Bulk fusion kinetics obscured
this heterogeneity and the observed lag phases in such ex-
periments only represented the time it took the first virions
to undergo hemifusion. The length and heterogeneity of the
lag phases before VACV fusion may reflect the complexity
of the fusion process, which may involve up to 11 viral com-
ponents of the entry/fusion complex (EFC) as well as two
proteins that presumably inhibit fusion until they dissociate
from the EFC at acidic pH (5,39). Interestingly, when Sem-
liki Forest virus or IAV particles were only brought in con-
tact with SLBs after acidification for ~1 s, the observed lag
phases between acidification and hemifusion were <1 s
(30). It is therefore possible that the interaction with attach-
ment factors in the host membrane, and perhaps their disso-
ciation, contributes to lag phases.
Although R18 dequenching occurred rapidly (<1 s) in all
single-virus fusion experiments with artificial membranes
(10,30,40), R18 dequenching during hemifusion of VACV
and IAV with the plasma membrane was slow. Fusion
of IAV to red blood cells (41), as well as fusion of
IAV, dengue virus, and retrovirus particles with endosomal
membranes (42–44), followed kinetics similar to that
Single Vaccinia Virus Fusion Analysis 429observed for the plasma-membrane fusion of VACV and
IAV described here. Our data suggest that diffusion of
R18 into biological membranes differs greatly from diffu-
sion into simple artificial bilayers. Single-virus fusion
kinetics with biological membranes therefore reveals valu-
able information on the kinetics of lipid mixing during phys-
iological fusion events. Interestingly, electron micrographs
of WR wild-type MVs fusing with the plasma membrane
showed that in many cases, the more electron-dense virus
membrane did not readily flatten into the plasma membrane,
but rather remained as a distinct entity (26,45). These elec-
tron micrographs may exemplify the slower lipid mixing
(and thus R18 dequenching) after fusion with biological
membranes.
Using the additional information obtained by observing
fusion microscopically, we found that virus cores were acid-
ified by the surrounding buffers and neutralized with some
delay after hemifusion. Relying on the acid-labile fluores-
cence of the core protein EGFP-A4, the respective changes
in EGFP fluorescence could be confirmed in bulk fusion
experiments. Low-pH-mediated quenching of palmitoylated
yellow fluorescent protein (YFP) in the interior of avian sar-
coma and leukosis virus (ASLV) has also been observed in
acid-induced fusion experiments (46). However, a drop of
YFP fluorescence was only observed in a fraction of the par-
ticles, implicating membrane defects as the most likely
explanation. In that study, recovery of YFP fluorescence
after fusion of ASLV was also used as a readout for content
mixing and fusion-pore formation. In our experiments,
EGFP fluorescence dropped in every core, suggesting that
the observed proton permeability of the virus membranes
is a general property of VACV MVs.
In our study, single fusion experiments acted as a discov-
ery tool that inspired bulk experiments that would not other-
wise have been performed. We postulate that proton
channels in the MV membrane allow the transport of pro-
tons into the viral interior, and that the pH is reelevated after
fusion-pore formation (Fig. 7). In this case, EGFP-A4 fluo-
rescence could be used as a marker for both core acidifica-
tion and content mixing.
The postulated proton channel in the virus membrane
would also transmit protons into the virus interior during
acidification of MV-containing endocytic vesicles, where
acidification may prepare the virus core for activation
or uncoating. Interestingly, it was previously observed
work that VACV entry involves two pH-dependent steps,
and that pretreatment of MVs with low pH enhances infec-
tion independent of fusion (47). Further experiments are
necessary to confirm the existence and identity of the postu-
lated proton channels in the VACV MV membrane. Since
proton channels or viral ion channels cannot be identified
based on sequence, identification of the postulated viral
proton channel would likely require a candidate approach.
This may involve the generation of individual conditional
knockout strains of the known MV membrane proteins(~25) (48) combined with measurement of EGFP-A4 fluo-
rescence after acidification. An alternative would be the het-
erologous expression of candidate genes in cells combined
with methods to directly measure ion fluxes.
Virus-encoded ion channels (viroporins), such as IAVM2,
hepatitis C virus p7, HIV-1 Vpu, or poliovirus p2, have been
shown to be crucial for viral pathogenicity (32). They modu-
late ion fluxes in modified cellular organelles or in the virus
particles themselves and are involved in diverse steps of the
viral life cycle, thus constituting an obvious target for
antiviral therapeutics. Poxviruses drastically modulate the
host-cell cytosol in multiple ways. It therefore does not
seem surprising that poxviruses have evolved proteins to
control proton concentrations in the virus and, perhaps, in in-
fected cells. The identification of poxvirus-encoded proton
channels would not only contribute to the understanding of
the poxvirus life cycle, but may also stimulate the develop-
ment of drugs inhibiting poxvirus infection.
EGFP-A4 fluorescence as a genetically encoded marker
for core pH could in principle be exploited to study the regu-
lation and rates of proton influx in detail. Similar studies
with fluorescein-loaded IAV particles allowed the determi-
nation of exact proton flux rates and a detailed characteriza-
tion of IAV M2 in the context of the virus (49).
Using microfluidics and TIRF microscopy in combination
with fluorescent virus particles, we visualized several impor-
tant steps before and during VACVMV fusion: acidification
of virus cores, hemifusion, and content mixing. Similar
approaches may therefore be helpful to investigate the
VACV MV fusion process more thoroughly and, of more
importance, to distinguishwhich perturbations directly affect
fusion rather than, e.g., endocytosis. It was shown in a recent
study that most of the EFC components and associated
proteins are required for hemifusion, whereas the absence
of A28, L1, or L5 only affects later steps, such as early
gene expression or the localization of cores in the cytosol
(26). An experimental setup with a genuine content-mixing
marker may help to elucidate the exact role of these proteins.
Our system could furthermore help to solve the ongoing
controversy regarding the fusion inhibitory dimer A25/A26
in the context of pH-dependent or pH-independent fusion
of MVs of VACV strains WR and IHD-J, respectively
(39,50).
The experimental setup described in this study can theo-
retically be applied to study fusion of any enveloped virus
for which fusion with the plasma membrane occurs natu-
rally or can be triggered artificially. The microfluidic device
could be adapted to more advanced fusion experiments,
where, e.g., the pH drop is more rapidly initiated under
no-flow conditions using caged protons (40), or where pH
gradients are applied. Since the described system allows
experiments with living cells, the effect of cellular factors
on fusion can also be investigated. For example, it was
recently proposed that antiviral proteins of the IFITM
family prevent virus hemifusion by reducing the fluidityBiophysical Journal 105(2) 420–431
430 Schmidt et al.of cellular membranes (51). However, in this study, syncytia
formation was used as the only readout for fusion. The
molecular details of this antiviral defense mechanism could
be elaborated by directly visualizing hemifusion using
microfluidics-based single-virus fusion experiments.CONCLUSION
We have set up a platform that allows for microscopy-based
observation and quantification of single-virus fusion events
at the plasma membrane. As shown for VACV MVs, micro-
scopic analysis of hemifusion can be combined with the
detection of other fluorescent signals, e.g., content markers.
This approach has already led to the novel finding that
VACV MV membranes are proton-permeable, presumably
due to a yet unidentified proton channel. In general, the
fairly simple and robust microfluidic method established
here is useful for a broad range of applications in the field
of cell biology and biophysics, where immobilization of sin-
gle cells and fast solution exchange are required for kinetic
and mechanistic investigations. In addition to studies on
virus-cell fusion, applications may include vesicle-cell
fusion, the penetration of cells with particles or molecules,
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